Cargando…
A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study
Background: Activation of the clotting-fibrinolytic system in cancer patients is common and results in an unfavorable clinical outcome. This study aimed to investigate the role of pretreatment plasma D-dimer levels and the combination of D-dimer and albumin (DA) on the prediction of survival prognos...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636283/ https://www.ncbi.nlm.nih.gov/pubmed/31333786 http://dx.doi.org/10.7150/jca.32387 |
_version_ | 1783436035985768448 |
---|---|
author | He, Sha-Sha Wang, Yan Wang, Cheng-tao Zhu, Mei-yan Yang, Xing-Li Chen, Dan-Ming Chen, Yong |
author_facet | He, Sha-Sha Wang, Yan Wang, Cheng-tao Zhu, Mei-yan Yang, Xing-Li Chen, Dan-Ming Chen, Yong |
author_sort | He, Sha-Sha |
collection | PubMed |
description | Background: Activation of the clotting-fibrinolytic system in cancer patients is common and results in an unfavorable clinical outcome. This study aimed to investigate the role of pretreatment plasma D-dimer levels and the combination of D-dimer and albumin (DA) on the prediction of survival prognosis in patients with nasopharyngeal carcinoma (NPC). Methods: The study comprised 511 patients with NPC. Pretreatment plasma D-dimer and serum albumin levels were measured. DA was classified as a new biomarker where D-dimer and albumin levels were combined and was grouped by the cutoff value of both. The correlations of plasma D-dimer levels with clinicopathological features and survival outcome were calculated using the Chi-square test. Kaplan-Meier estimates were performed to analyze the survival functions and were compared using log-rank tests. Cox proportional hazard regression analysis was used to assess the effects of D-dimer and DA on distant overall survival (OS) and distant metastasis-free survival (DMFS). Results: The median follow-up period was 45.2 months (range 2.1-79.8). Elevated plasma D-dimer levels were positively associated with age at diagnosis (P = 0.034), platelet levels (P = 0.043), and Epstein Barr Virus (EBV) DNA copy number (P = 0.035). Additionally, multivariate analysis demonstrated that elevated plasma D-dimer levels were strongly associated with a poorer OS (HR 2.074, 95% CI 1.190-3.612, P = 0.010), but not DMFS. After adjustment for other variables, DA stratification acted as an independent prognostic marker for OS (P = 0.038) and DMFS (P = 0.031) in patients with NPC, when combined with albumin levels. Conclusions: Increased plasma D-dimer levels accurately predict poor OS and may be an effective independent prognostic factor in patients with NPC. Moreover, in conjunction with serum albumin, DA may serve as a factor in predicting OS and DMFS. |
format | Online Article Text |
id | pubmed-6636283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-66362832019-07-22 A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study He, Sha-Sha Wang, Yan Wang, Cheng-tao Zhu, Mei-yan Yang, Xing-Li Chen, Dan-Ming Chen, Yong J Cancer Research Paper Background: Activation of the clotting-fibrinolytic system in cancer patients is common and results in an unfavorable clinical outcome. This study aimed to investigate the role of pretreatment plasma D-dimer levels and the combination of D-dimer and albumin (DA) on the prediction of survival prognosis in patients with nasopharyngeal carcinoma (NPC). Methods: The study comprised 511 patients with NPC. Pretreatment plasma D-dimer and serum albumin levels were measured. DA was classified as a new biomarker where D-dimer and albumin levels were combined and was grouped by the cutoff value of both. The correlations of plasma D-dimer levels with clinicopathological features and survival outcome were calculated using the Chi-square test. Kaplan-Meier estimates were performed to analyze the survival functions and were compared using log-rank tests. Cox proportional hazard regression analysis was used to assess the effects of D-dimer and DA on distant overall survival (OS) and distant metastasis-free survival (DMFS). Results: The median follow-up period was 45.2 months (range 2.1-79.8). Elevated plasma D-dimer levels were positively associated with age at diagnosis (P = 0.034), platelet levels (P = 0.043), and Epstein Barr Virus (EBV) DNA copy number (P = 0.035). Additionally, multivariate analysis demonstrated that elevated plasma D-dimer levels were strongly associated with a poorer OS (HR 2.074, 95% CI 1.190-3.612, P = 0.010), but not DMFS. After adjustment for other variables, DA stratification acted as an independent prognostic marker for OS (P = 0.038) and DMFS (P = 0.031) in patients with NPC, when combined with albumin levels. Conclusions: Increased plasma D-dimer levels accurately predict poor OS and may be an effective independent prognostic factor in patients with NPC. Moreover, in conjunction with serum albumin, DA may serve as a factor in predicting OS and DMFS. Ivyspring International Publisher 2019-06-09 /pmc/articles/PMC6636283/ /pubmed/31333786 http://dx.doi.org/10.7150/jca.32387 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper He, Sha-Sha Wang, Yan Wang, Cheng-tao Zhu, Mei-yan Yang, Xing-Li Chen, Dan-Ming Chen, Yong A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title | A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title_full | A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title_fullStr | A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title_full_unstemmed | A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title_short | A combined marker based on plasma D-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
title_sort | combined marker based on plasma d-dimer and serum albumin levels in patients with nasopharyngeal carcinoma is associated with poor survival outcomes in a retrospective cohort study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636283/ https://www.ncbi.nlm.nih.gov/pubmed/31333786 http://dx.doi.org/10.7150/jca.32387 |
work_keys_str_mv | AT heshasha acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT wangyan acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT wangchengtao acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT zhumeiyan acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT yangxingli acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT chendanming acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT chenyong acombinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT heshasha combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT wangyan combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT wangchengtao combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT zhumeiyan combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT yangxingli combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT chendanming combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy AT chenyong combinedmarkerbasedonplasmaddimerandserumalbuminlevelsinpatientswithnasopharyngealcarcinomaisassociatedwithpoorsurvivaloutcomesinaretrospectivecohortstudy |